Laurus Labs Q3 Results: Strong Growth and Future Outlook for FY25

Alivus Life Sciences Q3: A Strong Performance Report Alivus Life Sciences showcased remarkable growth in its Q3 performance, reflecting its focused strategies and efforts to drive innovation. The company achieved significant progress across multiple business segments, including GPL (Generic Product…